TCM
LEGN icon

Tang Capital Management’s Legend Biotech LEGN Stock Holding History

Tang Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-830,000
Closed -$27.1M – 142
2025
Q3 		$27.1M Hold
830,000
– – 1.04% 28
2025
Q2 		$29.5M Hold
830,000
– – 1.49% 19
2025
Q1 		$28.2M Buy
830,000
+380,000
+84% +$13.6M 1.56% 16
2024
Q4 		$14.6M Buy
+450,000
New +$18.6M 0.97% 28
2023
Q1 		– Sell
-60,000
Closed -$3M – 115
2022
Q4 		$3M Sell
60,000
-20,000
-25% -$969K 0.44% 53
2022
Q3 		$3.26M Buy
80,000
+30,000
+60% +$1.41M 0.4% 57
2022
Q2 		$2.75M Hold
50,000
– – 0.42% 46
2022
Q1 		$1.82M Sell
50,000
-150,000
-75% -$5.93M 0.36% 48
2021
Q4 		$9.32M Buy
+200,000
New +$10.1M 1.87% 15

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tang Capital Management's LEGN Position: Q4 2025 in Review

Tang Capital Management sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 830,000 shares — an estimated $27.1M sold.

Tang Capital Management first reported a position in LEGN in Q4 2021 and held it in 9 quarters. The position peaked at $29.5M in Q2 2025. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Tang Capital Management reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 830,000 Legend Biotech shares in Q4 2025, an estimated $27.1M.
  • Tang Capital Management first reported a position in Legend Biotech in Q4 2021 and held it in 9 quarters.
  • Tang Capital Management's Legend Biotech position peaked at $29.5M in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.